Comparative fluorimetric strategies for determination of landiolol hydrochloride using native fluorescence and green synthesized silver nanoparticles

M Marwa Khaled H Hend Z. Yamani N Nermine V. Fares A Amira M. El-Kosasy

Abstract

Abstract This study introduces the first reported stepwise fluorimetric strategy for the sensitive and rapid determination of the ultra-short-acting β₁-blocker, landiolol hydrochloride. Initially, an environmentally benign method was developed by exploiting the drug’s native fluorescence in water (λ ex /λ em  = 217/298 nm). While this cost-effective approach successfully utilized water as a green solvent, it demonstrated limited LOD of 32.57 ng/mL. To enhance fluorescence performance, various organic solvents were investigated, with acetonitrile providing the highest signal at λ ex /λ em  = 222/300 nm and improving the LOD to 16.31 ng/mL. To enable ultra-trace clinical monitoring, a third “turn-on” method was developed using silver nanoparticles (AgNPs). By measuring fluorescence enhancement at λ ex /λ em  = 260/524.6 nm upon interaction with landiolol, this platform amplifies the signal, achieving an outstanding LOD of 3.10 ng/mL. AgNPs were prepared using a green synthesis approach employing Aloe vera extract as a natural reducing and stabilizing agent in an aqueous medium avoiding using hazardous chemicals. Water was used throughout both nanoparticle preparation and the AgNP-enhanced determination, reinforcing the eco-friendly profile of the method. Unlike native fluorescence, the AgNP-assisted method enhances sensitivity through nanoparticle-mediated surface passivation, with a possible auxiliary contribution from resonance energy transfer (RET)-like processes. Selectivity is improved through preferential adsorption of landiolol on the AgNP surface and a large Stokes shift that minimizes interference from UV-absorbing matrix components. The resulting enhanced sensitivity and reduced matrix interference make this method a powerful tool for ultra-trace, selective, and sustainable determination of landiolol in pharmaceutical formulations and human plasma, demonstrating its suitability for routine quality control and bioanalytical applications.

Article Details

Volume / Issue Vol. 16, Issue 1
Published July 28, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (4)

M

Marwa Khaled

H

Hend Z. Yamani

N

Nermine V. Fares

A

Amira M. El-Kosasy